The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2003
DOI: 10.1046/j.1460-9568.2003.02621.x
|View full text |Cite
|
Sign up to set email alerts
|

Impaired glutamate uptake and EAAT2 downregulation in an enterovirus chronically infected human glial cell line

Abstract: Rapid and efficient uptake of glutamate via the high-affinity glutamate transporter EAAT2 is important for limiting glutamate-mediated excitotoxicity involved in neuronal death. Furthermore, there is evidence of altered glutamate uptake and catabolism in motor neuron diseases. Such a defect has been reported in amyotrophic lateral sclerosis, the major motor neuron disease, and was associated with impairment in EAAT2 processing. We recently reported the presence of enterovirus genome specifically in the anterio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
8
0

Year Published

2005
2005
2017
2017

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 44 publications
1
8
0
Order By: Relevance
“…cDNA was amplified using primers specific for EAAT-2 [36]. PCR for EAAT-2 was run for 35 cycles using the following conditions: 95 °C for 45 s, 55 °C for 1 min, and 72 °C for 1 min.…”
Section: Methodsmentioning
confidence: 99%
“…cDNA was amplified using primers specific for EAAT-2 [36]. PCR for EAAT-2 was run for 35 cycles using the following conditions: 95 °C for 45 s, 55 °C for 1 min, and 72 °C for 1 min.…”
Section: Methodsmentioning
confidence: 99%
“…In vitro, the virus can establish a chronic infection in the human pre-astrocytes cell line, the Dev cells. Although the morphological aspect of infected Dev cells does not change, this chronic infection provokes some modifications in cell biology: a down regulation of the expression of a cellular receptor-transporter of glutamate (EAAT2) leading to a decrease of glutamate uptake [25]. This was attributed to an abnormal splicing of the pre-messenger RNA.…”
Section: Discussionmentioning
confidence: 99%
“…The specificity of glutamate splice variants in neurodegenerative diseases remains unknown because aberrant splicing of glutamate transporters was also reported in other neurological disorders including hypoxia , traumatic brain injury , epilepsy (Hoogland et al, 2004), Alzheimer disease (Maragakis et al, 2004), Huntington disease (Hoogland et al, 2004), AIDS dementia complex , multiple sclerosis (Vallejo-Illarramendi et al, 2006), olivopontocerebellar atrophy (Dirson et al, 2002), schizophrenia (Lauriat et al, 2006), and glaucoma . Altered glutamate transport and aberrant splicing of EAAT2 expression was also reported in glial cells from ALS patients infected with enterovirus (Legay et al, 2003). It still remains unknown whether changes in expression and distribution of splice variants of EAAT2 are the cause or consequence of EAAT2 activity.…”
Section: Glutamate Transporters In Neurological Disordersmentioning
confidence: 98%